Clinical Trial Update: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase IIa study sponsored by Changzhou Qianhong Bio-pharma Co., Ltd. evaluating safety and efficacy in relapsed/refractory acute myeloid leukemia; recruiting cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Changzhou Qianhong Bio-pharma Co., Ltd. | Conditions: Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) | Phase 2 | Status: RECRUITING